Gastro-oesophageal cancers

Our work focuses on the early detection and treatment of cancer of the oesophagus. Oesophageal cancers are the 8th most common cancer worldwide and the 6th most common cause of cancer death with only 15% surviving 5 years. The two main subtypes of oesophageal cancer: adenocarcinoma and squamous cell carcinoma (OSCC) have a remarkably improved survival when diagnosed at an early stage.

Our main research aims are to:

Understand the underlying clinical, genetic and cell environmental factors that lead to the conversion of a low-risk pre-malignant state into invasive cancer.

Find new diagnostic tools that will identify those patients who are at an increased risk of developing cancer.

We work as a highly diverse multi-disciplinary team which includes nurses, clinicians, statisticians, laboratory scientists, computational biologists, pathologists, data managers and administrators. We have a pragmatic approach to research which comes from a working knowledge of the clinical disease with the aim of translating our research findings into clinical practice.

Contact

Rebecca is interested in hearing from anyone with a clinical or scientific background interested in joining the laboratory or clinical infrastructure team at any time. Click here to contact Professor Rebecca Fitzgerald by email.